Epi-Shugarcaine Kit Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1409-60
Published November 7, 2018 · Recall initiated: September 10, 2018
Summary
FDA records drug Class II recall D-0151-2019, published November 7, 2018 and initiated September 10, 2018. Recalling firm: Pharm D Solutions, LLC; Status: Terminated; Reported quantity: 70 bottles; Lot: 08272018:79 Discard by: 10/1/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Pharm D Solutions, LLC
- Distributor
- Nationwide
- Lot
- 08272018:79 Discard by: 10/1/2018
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATestosterone 200 mg/mL, 30 mL vials, Rx only, Pharm D. Solutions 1304 South Loop West, Houston, TX 77054,June 19, 2019
- FDAHuman Chorionic Gonadotropin 12,000 IU vials Pharm D. Solutions 1304 South Loop West, Houston, TX 77054,June 19, 2019
- FDAHuman Chorionic Gonadotropin 5,000 IU vials, Rx only, Pharm D. Solutions 1304 South Loop West, Houston, TXJune 19, 2019
- FDAIpamorelin Acetate 9 mg/9mL Injectable vials, Rx only, Pharm D. Solutions 1304 South Loop West, Houston, TXJune 19, 2019
- FDADexpanthenol Injection, 250 mg/mL Pharm D Solutions, Houston, Texas --- NDC 69699-1610-30November 7, 2018
- FDAEpinepherine 1 mg/1 mL 3 mL Injectable Pharm D Solutions, Houston, Texas ---- NDC 69699-0109-03November 7, 2018
Questions about this recall
Was Epi-Shugarcaine Kit Solution Pharm D Solutions, Houston, Texas --- NDC 69699-1409-60 recalled?
Yes. FDA published recall D-0151-2019 on November 7, 2018. Reported hazard: Lack of Assurance of Sterility
What should I do if I have this product?
Voluntary: Firm initiated · Press Release